59 related articles for article (PubMed ID: 20469914)
1. Scalable synthesis of a prostaglandin EP4 receptor antagonist.
Gauvreau D; Dolman SJ; Hughes G; O'Shea PD; Davies IW
J Org Chem; 2010 Jun; 75(12):4078-85. PubMed ID: 20469914
[TBL] [Abstract][Full Text] [Related]
2. Remote electronic control in the regioselective reduction of succinimides: a practical, scalable synthesis of Ep4 antagonist MF-310.
Molinaro C; Gauvreau D; Hughes G; Lau S; Lauzon S; Angelaud R; O'Shea PD; Janey J; Palucki M; Hoerrner SR; Raab CE; Sidler RR; Belley M; Han Y
J Org Chem; 2009 Sep; 74(17):6863-6. PubMed ID: 19663395
[TBL] [Abstract][Full Text] [Related]
3. The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.
Blouin M; Han Y; Burch J; Farand J; Mellon C; Gaudreault M; Wrona M; Lévesque JF; Denis D; Mathieu MC; Stocco R; Vigneault E; Therien A; Clark P; Rowland S; Xu D; O'Neill G; Ducharme Y; Friesen R
J Med Chem; 2010 Mar; 53(5):2227-38. PubMed ID: 20163116
[TBL] [Abstract][Full Text] [Related]
4. Multicatalytic synthesis of alpha-pyrrolidinyl ketones via a tandem palladium(II)/indium(III)-catalyzed aminochlorocarbonylation/Friedel-Crafts acylation reaction.
Cernak TA; Lambert TH
J Am Chem Soc; 2009 Mar; 131(9):3124-5. PubMed ID: 19209934
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric hydrogenation of prochiral amino ketones to amino alcohols for pharmaceutical use.
Klingler FD
Acc Chem Res; 2007 Dec; 40(12):1367-76. PubMed ID: 18052332
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Diarylthiophenes as selective EP1 receptor antagonists.
Ducharme Y; Blouin M; Carrière MC; Chateauneuf A; Côté B; Denis D; Frenette R; Greig G; Kargman S; Lamontagne S; Martins E; Nantel F; O'Neill G; Sawyer N; Metters KM; Friesen RW
Bioorg Med Chem Lett; 2005 Feb; 15(4):1155-60. PubMed ID: 15686932
[TBL] [Abstract][Full Text] [Related]
7. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 receptor EP4-selective antagonist inhibits lipopolysaccharide-induced cervical ripening in rabbits.
Fukuda Y; Sugimura M; Suzuki K; Kanayama N
Acta Obstet Gynecol Scand; 2007; 86(11):1297-302. PubMed ID: 17963056
[TBL] [Abstract][Full Text] [Related]
9. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
[TBL] [Abstract][Full Text] [Related]
10. A ring-expansion approach to roseophilin.
Salamone SG; Dudley GB
Org Lett; 2005 Sep; 7(20):4443-5. PubMed ID: 16178554
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells.
Takita M; Inada M; Maruyama T; Miyaura C
FEBS Lett; 2007 Feb; 581(3):565-71. PubMed ID: 17254571
[TBL] [Abstract][Full Text] [Related]
12. Expression of prostaglandin receptors EP4 and FP in human lens epithelial cells.
Mukhopadhyay P; Bhattacherjee P; Andom T; Geoghegan TE; Andley UP; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):105-12. PubMed ID: 9888433
[TBL] [Abstract][Full Text] [Related]
13. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
14. Biocatalytic strategies for the asymmetric synthesis of alpha-hydroxy ketones.
Hoyos P; Sinisterra JV; Molinari F; Alcántara AR; Domínguez de María P
Acc Chem Res; 2010 Feb; 43(2):288-99. PubMed ID: 19908854
[TBL] [Abstract][Full Text] [Related]
15. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O
Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136
[TBL] [Abstract][Full Text] [Related]
16. Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonists.
Hattori K; Tanaka A; Fujii N; Takasugi H; Tenda Y; Tomita M; Nakazato S; Nakano K; Kato Y; Kono Y; Murai H; Sakane K
J Med Chem; 2005 May; 48(9):3103-6. PubMed ID: 15857112
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors.
Hatazawa R; Tanigami M; Izumi N; Kamei K; Tanaka A; Takeuchi K
Inflammopharmacology; 2007 Oct; 15(5):214-7. PubMed ID: 17943254
[TBL] [Abstract][Full Text] [Related]
19. Highly enantioselective Friedel-Crafts reaction of thiophenes with glyoxylates: formal synthesis of duloxetine.
Majer J; Kwiatkowski P; Jurczak J
Org Lett; 2009 Oct; 11(20):4636-9. PubMed ID: 19764789
[TBL] [Abstract][Full Text] [Related]
20. Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats.
Aoi M; Aihara E; Nakashima M; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G96-103. PubMed ID: 15194560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
